These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35835867)

  • 1. Inactive and active state structures template selective tools for the human 5-HT
    Zhang S; Chen H; Zhang C; Yang Y; Popov P; Liu J; Krumm BE; Cao C; Kim K; Xiong Y; Katritch V; Shoichet BK; Jin J; Fay JF; Roth BL
    Nat Struct Mol Biol; 2022 Jul; 29(7):677-687. PubMed ID: 35835867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SB-699551-A (3-cyclopentyl-N-[2-(dimethylamino)ethyl]-N-[(4'-{[(2-phenylethyl)amino]methyl}-4-biphenylyl)methyl]propanamide dihydrochloride), a novel 5-ht5A receptor-selective antagonist, enhances 5-HT neuronal function: Evidence for an autoreceptor role for the 5-ht5A receptor in guinea pig brain.
    Thomas DR; Soffin EM; Roberts C; Kew JN; de la Flor RM; Dawson LA; Fry VA; Coggon SA; Faedo S; Hayes PD; Corbett DF; Davies CH; Hagan JJ
    Neuropharmacology; 2006 Sep; 51(3):566-77. PubMed ID: 16846620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of spinal 5-HT5A, and 5-HT1A/1B/1D, receptors in neuropathic pain induced by spinal nerve ligation in rats.
    Avila-Rojas SH; Velázquez-Lagunas I; Salinas-Abarca AB; Barragán-Iglesias P; Pineda-Farias JB; Granados-Soto V
    Brain Res; 2015 Oct; 1622():377-85. PubMed ID: 26168890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Based Design of a Chemical Probe Set for the 5-HT
    Levit Kaplan A; Strachan RT; Braz JM; Craik V; Slocum S; Mangano T; Amabo V; O'Donnell H; Lak P; Basbaum AI; Roth BL; Shoichet BK
    J Med Chem; 2022 Mar; 65(5):4201-4217. PubMed ID: 35195401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-hydroxytryptamine (5-HT) receptor ligands.
    Kitson SL
    Curr Pharm Des; 2007; 13(25):2621-37. PubMed ID: 17897004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latest advances towards the discovery of 5-HT(7) receptor ligands.
    Pittala V; Pittala D
    Mini Rev Med Chem; 2011 Nov; 11(13):1108-21. PubMed ID: 22353220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insight into the serotonin (5-HT) receptor family by molecular docking, molecular dynamics simulation and systems pharmacology analysis.
    Wang YQ; Lin WW; Wu N; Wang SY; Chen MZ; Lin ZH; Xie XQ; Feng ZW
    Acta Pharmacol Sin; 2019 Sep; 40(9):1138-1156. PubMed ID: 30814658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal 5-HT₅A receptors mediate 5-HT-induced antinociception in several pain models in rats.
    Muñoz-Islas E; Vidal-Cantú GC; Bravo-Hernández M; Cervantes-Durán C; Quiñonez-Bastidas GN; Pineda-Farias JB; Barragán-Iglesias P; Granados-Soto V
    Pharmacol Biochem Behav; 2014 May; 120():25-32. PubMed ID: 24517902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of noradrenaline release via presynaptic 5-HT1D alpha receptors in human atrium.
    Molderings GJ; Frölich D; Likungu J; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):272-80. PubMed ID: 8692281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
    Meller E; Li H; Carr KD; Hiller JM
    J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities.
    Sleight AJ; Stam NJ; Mutel V; Vanderheyden PM
    Biochem Pharmacol; 1996 Jan; 51(1):71-6. PubMed ID: 8534270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
    Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D
    J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT5 receptors.
    Nelson DL
    Curr Drug Targets CNS Neurol Disord; 2004 Feb; 3(1):53-8. PubMed ID: 14965244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
    Pauwels PJ; Van Gompel P; Leysen JE
    Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT(7) receptors activate the mitogen activated protein kinase extracellular signal related kinase in cultured rat hippocampal neurons.
    Errico M; Crozier RA; Plummer MR; Cowen DS
    Neuroscience; 2001; 102(2):361-7. PubMed ID: 11166122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterisation of 5-HT receptors positively coupled to adenylyl cyclase in the rat hippocampus.
    Markstein R; Matsumoto M; Kohler C; Togashi H; Yoshioka M; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):454-9. PubMed ID: 10431755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insights into the ligand binding and G
    Tan Y; Xu P; Huang S; Yang G; Zhou F; He X; Ma H; Xu HE; Jiang Y
    Cell Discov; 2022 May; 8(1):50. PubMed ID: 35610220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in 5-HT1B/1D receptor antagonists and agonists and their potential therapeutic applications.
    Slassi A
    Curr Top Med Chem; 2002 Jun; 2(6):559-74. PubMed ID: 12052194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligands for the investigation of 5-HT autoreceptor function.
    Roberts C; Price GW; Middlemiss DN
    Brain Res Bull; 2001 Nov; 56(5):463-9. PubMed ID: 11750791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The putative <> 5-HT(1A) receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT(1A) receptors.
    Cosi C; Koek W
    Eur J Pharmacol; 2000 Jul; 401(1):9-15. PubMed ID: 10915831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.